Iain James MacLeod

Aldatu Biosciences, Inc.

NIH Rank #2813
  • Early Career

NIH Funding · FY2024

Total Funding
$2.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,813
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.9M across 3 grants · National rank #2813.

Top grants by award amount

Iain James MacLeod's NIH grant portfolio, ranked by award amount.

  • 2R44AI157650-03R44
    PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
    $986.9K
    award amount
  • 5SB1AI128974-06SB1
    Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.
    $957.8K
    award amount
  • 5R44AI172551-03R44
    PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
    $943.2K
    award amount

Affiliation

Institutions that have administered grants for Iain James MacLeod.

Affiliated with Aldatu Biosciences, Inc. (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Aldatu Biosciences, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2813
  6. 2024
    Entered Top 25% Nationally
    Ranked #2813